Expres2ion Biotech Holding AB (EXPRS2) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Expres2ion Biotech Holding AB

Intervacc AB

Xintela AB

Phase Holographic Imaging AB

Lipum AB

SenzaGen AB

Active Biotech AB

AlzeCure Pharma AB

Toleranzia AB

Bioextrax AB

Alligator Bioscience AB

Why is Expres2ion Biotech Holding AB ?

Flat results in Mar 26

NET SALES(HY) At SEK 1.47 MM has Grown at -23.72%
RAW MATERIAL COST(Y) Grown by 18.74% (YoY)
CASH AND EQV(HY) Lowest at SEK 69.4 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -84.67%, its profits have fallen by -4.6%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -84.67% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Expres2ion Biotech Holding AB for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Expres2ion Biotech Holding AB

-84.67%

-0.89

108.33%

OMX Stockholm 30

27.7%

1.79

15.50%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-18.77%

EBIT Growth (5y)

-11.32%

EBIT to Interest (avg)

-82.39

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.13

Sales to Capital Employed (avg)

0.09

Tax Ratio

16.25%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.37

EV to EBIT

-0.04

EV to EBITDA

-0.04

EV to Capital Employed

-0.16

EV to Sales

0.51

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-106.72%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

Bullish

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

OPERATING CASH FLOW(Y)

Highest at SEK -46.05 MM

NET PROFIT(HY)

Higher at SEK -17.77 MM

EPS(Q)

Highest at SEK -0.97

-8What is not working for the Company

NET SALES(HY)

At SEK 1.47 MM has Grown at -23.72%

RAW MATERIAL COST(Y)

Grown by 18.74% (YoY

CASH AND EQV(HY)

Lowest at SEK 69.4 MM

DEBT-EQUITY RATIO (HY)

Highest at -77.97 %

OPERATING PROFIT(Q)

Lowest at SEK -17.47 MM

Here's what is working for Expres2ion Biotech Holding AB

Operating Cash Flow

Highest at SEK -46.05 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Net Profit

Higher at SEK -17.77 MM

than preceding 12 month period ended Mar 2026

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (SEK MM)

EPS

Highest at SEK -0.97

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (SEK)

Here's what is not working for Expres2ion Biotech Holding AB

Net Sales

At SEK 1.47 MM has Grown at -23.72%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (SEK MM)

Operating Profit

Lowest at SEK -17.47 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (SEK MM)

Cash and Eqv

Lowest at SEK 69.4 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at -77.97 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost

Grown by 18.74% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales